Dermatitis atópica: evaluación de la gravedad y el control de la enfermedad durante la pandemia por COVID-19, y determinación del riesgo cardiovascular en pacientes adultos.

Abstract

To evaluate the clinical course of atopic dermatitis (AD) in adults during the COVID-19 pandemic and to evaluate their comorbidities and cardiovascular risk. A cross-sectional study was conducted in adults with AD. Severity and control of AD, quality of life, levels of psychological stress, depression and cardiovascular risk were measured. Forty-two patients were included. A decrease in POEM score (11.83 vs 10.12; p=0.004) and PO-SCORAD (37.77 vs 32.49; p= 0.001) was observed in comparison to the scores at pandemic onset. The quality of life correlated with the severity of AD (p<0.0001) while the levels of stress and depression did not show association. Most patients had a low cardiovascular risk. The results suggest a decrease in the current severity of AD compared with severity before pandemic. Quality of life is associated with AD severity.